glp-1 review article receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Glucagon-like peptide-1 receptor agonists and

The MRL Histology and Biochemistry Assay Lab Core facilities received funding from the MRC Metabolic Diseases Unit [MRC_MC_UU_12012/5] and the Imaging Core through a Wellcome Trust Strategic Award [100574/Z/12/Z]

Long-standing diabetes often damages nerves, most visibly as numbness in the feet or problems with balance, but it can also affect the autonomic nerves that help coordinate erections

Pharmacokinetically, these drugs are built for once-weekly dosing with long half-lives, so lower weekly doses really do produce lower overall exposure

These mechanisms include a thick polysaccharide capsule that surrounds the cell and melanin, a dark pigment that coats the exterior of the cell and helps neutralize offending oxidants

On January 6, 2025, the Department of Justice announced that Athira Pharma agreed to pay $4,068,698 to settle False Claims Act allegations